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Abstract 
This editorial introduces this volume of the Procedia in Vaccinology 
Keywords:  Vaccines, adjuvants, public perceptions 
This volume of the Procedia in Vaccinology has drawn on the papers and posters of the 3rd Vaccine Congress 
arranged by Elsevier as publishers of the journal Vaccine and the International Society for Vaccines that was held in 
Singapore at the beginning of October, 2009. It reflects the meeting in that the papers range widely over the subject 
area and approach each topic with a view to taking the subject forward.
One of the most exciting areas in vaccine development is that of the stimulation of the immune system by the use of 
adjuvants. Although we have not yet achieved full control of the humoral and cellular arms of the immune system 
we seem be increasing in our ability to stimulate the differentiation, growth and functionality of the T-Cells. The 
need to recognize and modulate (downregulate) the activities of the T-Reg cells is becoming increasingly apparent. 
In this Procedia we have papers that advance the field in the area of microgel, oil emulsion, astagalaus 
polysaccharides, cytokines, viral component  adjuvants and in the preservative complex based on the simple sugar, 
trehalose.  It has also to be noted that the delivery of these materials to the vaccinee is also a crucial area for 
examination and experimentation as to how it is possible to deliver the vaccines free from pain and in as few a 
number of doses as possible. There is a clear need for a coherent understanding of the way the delivery and 
presentation of a vaccine radically affects the properties of that vaccine and where possible to use an oral or nasal 
delivery method as was described for a putative vaccine for Hepatitis B and C.. 
In the papers dealing with vaccines we have to note that influenza vaccines continue to command attention. This 
disease of humans and their associated mammalian species provides a basic problem in Vaccinology – namely that 
of the discovery of a vaccine that protects against all strains and subtypes of influenza whatever mammalian species 
becomes infected. It is well known that the Haemagluttinin of this virus expresses both variable immunodominant 
and stable and conserved immunorecessive epitopes that can stimulate the production of neutralizing antibody. But 
it is an ancient scourge of humans, Tuberculosis, that has attracted the attention of an author in this volume. Using a 
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constructed virus based on the envelope of the Human Virus of Japan  manipulated to contain the DNA for the Heat 
Shock Protein of Tuberculosis adjuvanted by a coupled Interleukin-12  DNA it seems that a new line of attach is 
being attempted to break down the immunity of this persistent human pathogen. Other papers in this volume cover 
the use of a bacterial vectors for the delivery of putative immunogens from Enterovirus71, the screening of 
Burkholderia for immunogens and the construction of recombinant vaccines for Fasciolosis. A technology for the 
production of Vi antigens of Salmonella is also described. 
Vaccines do not achieve their function until they are administered to a vaccinee. Much attention recently has been 
given to the interface between the vaccinator and the vaccinatee. Papers in this volume reflect that situation in 
covering issues related to vaccine uptake, herd immunity and the mandatory vaccination of health care workers who 
may under particular circumstances refuse or object to vaccination.
We yet have a long way to go to fully exploit the potential of vaccination to enhance the well being of humans and 
their animals. Indeed, this volume contains papers that show the need for vaccines to protect against Dengue and 
there are many more emergent diseases in this category. In sum, the papers presented in this congress give testimony 
to the great efforts and exemplary virtuosity that are being devoted to the invention of vaccines that will make this 
world a safer and fairer place for all its occupants. 
